Brands

PAI Pharma acquires Nexus Pharmaceuticals, expanding portfolio of sterile injectable products

PAI Pharma, has acquired Nexus Pharmaceuticals, a pharmaceutical company specialising in the development and commercialisation of injectable medicines used in critical care, oncology, and...

First FDA breakthrough therapy designation in PSMA PET imaging granted to Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer

The United States Food and Drug Administration (FDA) has granted Clarity Pharmaceuticals’ 64Cu-SAR-bisPSMA breakthrough therapy designation for positron emission tomography (PET) of prostate-specific membrane...

Vasa Therapeutics announces positive topline results from randomised, placebo-controlled phase 1c trial of VS-041 for treatment of heart failure with preserved ejection fraction (HFpEF)

Vasa Therapeutics has announced positive results from a randomised, placebo-controlled phase 1c trial of its lead investigational therapy, VS-041, a narrow spectrum small molecule...

Orphalan expands global phase 3 study in Wilson disease to China marking first patient randomised worldwide

Orphalan SA today announced the expansion of the study into China, marking the formal randomisation of the first participant into the study globally. The...

Lilly breaks ground in Pennsylvania’s Lehigh Valley on a $3.5 billion site

Eli Lilly and Company has commenced building a $3.5 billion manufacturing facility in Pennsylvania's Lehigh Valley. The site is one of 10 new US manufacturing...

UAE investment drives Middle East biopharma transformation as precision medicine set for double-digit growth

The UAE is laying the foundations for the Middle East’s next phase of biopharma growth, with national investment in genomics, artificial intelligence (AI) and...

Plan now to visit World Health Expo (WHX) in Dubai 2027 25–28 January 2027, Dubai Exhibition Centre (DEC), Expo City and Dubai World Trade...

World Health Expo (WHX) 2027 is a leading B2B healthcare event bringing together healthcare professionals, decision-makers, innovators and organisations from across the global healthcare...

PacBio and Verily Health announce multi-year strategic collaboration to scale long-read genomics for biomedical AI

PacBio, a developer of advanced sequencing technologies, and Verily Health, a healthcare data intelligence company, have announced a multi-year strategic collaboration to integrate PacBio HiFi...
- Advertisement -
- Advertisement -

Latest stories